![D J Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
D J Kim
Plus aucun poste en cours
Profil
D J Kim worked as Vice President, Head-Research & Development at Rexahn Pharmaceuticals, Inc. and as Chief Scientific Officer at Chemgenomics, Inc. He completed his undergraduate degree at Seoul National University and his doctorate degree at Korea Advanced Institute of Science & Technology.
Anciens postes connus de D J Kim
Sociétés | Poste | Fin |
---|---|---|
Chemgenomics, Inc. | Directeur Technique/Scientifique/R&D | - |
REXAHN PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de D J Kim
Seoul National University | Undergraduate Degree |
Korea Advanced Institute of Science & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 2 |
---|---|
Rexahn Pharmaceuticals, Inc.
![]() Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
Chemgenomics, Inc. |